500.35MMarket Cap-3801P/E (TTM)
12.456High10.920Low2.15MVolume11.080Open11.070Pre Close24.37MTurnover9.97%Turnover RatioLossP/E (Static)42.19MShares16.88052wk High5.65P/B256.15MFloat Cap7.21052wk Low--Dividend TTM21.60MShs Float129.108Historical High--Div YieldTTM13.87%Amplitude4.120Historical Low11.317Avg Price1Lot Size
KalVista Pharmaceuticals Stock Forum
Ph 3 readouts in Q1 2024...
$Regenxbio(RGNX.US)$ Phase 3
$Annovis Bio(ANVS.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 3
$Vertex Pharmaceuticals(VRTX.US)$ Phase 3
$KalVista Pharmaceuticals(KALV.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$Novocure(NVCR.US)$ Phase 3
$ROCHE HOLDING AG(RHHBY.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$Applied Therapeutics(APLT.US)$ Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$ Phase 3...
could be something brewing here
No comment yet